Krish S. Krishnan - 11 Jun 2024 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Signature
/s/ Krish S. Krishnan
Issuer symbol
KRYS
Transactions as of
11 Jun 2024
Net transactions value
-$8,788,062
Form type
4
Filing time
11 Jun 2024, 20:31:51 UTC
Previous filing
11 Mar 2024
Next filing
13 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRYS Common Stock Sale $188,637 -1,100 -0.07% $171.49 1,611,162 11 Jun 2024 Direct F1, F2
transaction KRYS Common Stock Sale $324,104 -1,882 -0.12% $172.21 1,609,280 11 Jun 2024 Direct F1, F3
transaction KRYS Common Stock Sale $228,657 -1,318 -0.08% $173.49 1,607,962 11 Jun 2024 Direct F1, F4
transaction KRYS Common Stock Sale $699,304 -4,000 -0.25% $174.83 1,603,962 11 Jun 2024 Direct F1, F5
transaction KRYS Common Stock Sale $799,693 -4,550 -0.28% $175.76 1,599,412 11 Jun 2024 Direct F1, F6
transaction KRYS Common Stock Sale $1,007,951 -5,705 -0.36% $176.68 1,593,707 11 Jun 2024 Direct F1, F7
transaction KRYS Common Stock Sale $967,814 -5,447 -0.34% $177.68 1,588,260 11 Jun 2024 Direct F1, F8
transaction KRYS Common Stock Sale $178,000 -998 -0.06% $178.36 1,587,262 11 Jun 2024 Direct F1, F9
transaction KRYS Common Stock Sale $154,257 -900 -0.06% $171.40 1,549,982 11 Jun 2024 By Spouse F2, F10, F11, F12
transaction KRYS Common Stock Sale $361,529 -2,099 -0.14% $172.24 1,547,883 11 Jun 2024 By Spouse F10, F11, F12, F13
transaction KRYS Common Stock Sale $209,137 -1,206 -0.08% $173.41 1,546,677 11 Jun 2024 By Spouse F10, F11, F12, F14
transaction KRYS Common Stock Sale $300,831 -1,724 -0.11% $174.50 1,544,953 11 Jun 2024 By Spouse F10, F11, F12, F15
transaction KRYS Common Stock Sale $872,273 -4,975 -0.32% $175.33 1,539,978 11 Jun 2024 By Spouse F10, F11, F12, F16
transaction KRYS Common Stock Sale $1,034,792 -5,867 -0.38% $176.38 1,534,111 11 Jun 2024 By Spouse F10, F11, F12, F17
transaction KRYS Common Stock Sale $1,127,773 -6,358 -0.41% $177.38 1,527,753 11 Jun 2024 By Spouse F10, F11, F12, F18
transaction KRYS Common Stock Sale $333,309 -1,871 -0.12% $178.14 1,525,882 11 Jun 2024 By Spouse F10, F11, F12, F19
holding KRYS Common Stock 90,000 11 Jun 2024 By Krishnan Spousal Trust
holding KRYS Common Stock 50,000 11 Jun 2024 By Krishnan Family Trust F20
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on September 11, 2023, and contemplated quarterly sales of 25,000 shares with a limit price of $100.00 per share. The Rule 10b5-1 trading plan has reached the maximum number of shares to be sold under such plan and has terminated.
F2 The transaction was executed in multiple trades ranging from $170.75 to $171.74. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 The transaction was executed in multiple trades ranging from $171.83 to $172.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 The transaction was executed in multiple trades ranging from $172.85 to $173.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5 The transaction was executed in multiple trades ranging from $174.21 to $175.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F6 The transaction was executed in multiple trades ranging from $175.21 to $176.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F7 The transaction was executed in multiple trades ranging from $176.21 to $177.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F8 The transaction was executed in multiple trades ranging from $177.21 to $178.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F9 The transaction was executed in multiple trades ranging from $178.24 to $178.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F10 The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma M. Krishnan. The Rule 10b5-1 trading plan started on September 11, 2023, and contemplated quarterly sales of 25,000 shares with a limit price of $100.00 per share. The Rule 10b5-1 trading plan has reached the maximum number of shares to be sold under such plan and has terminated.
F11 These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma M. Krishnan.
F12 Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person.
F13 The transaction was executed in multiple trades ranging from $171.84 to $172.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F14 The transaction was executed in multiple trades ranging from $172.85 to $173.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F15 The transaction was executed in multiple trades ranging from $173.85 to $174.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F16 The transaction was executed in multiple trades ranging from $174.85 to $175.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F17 The transaction was executed in multiple trades ranging from $175.85 to $176.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F18 The transaction was executed in multiple trades ranging from $176.85 to $177.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F19 The transaction was executed in multiple trades ranging from $177.85 to $178.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F20 Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and his spouse are each joint beneficial owners of the trust with joint voting and investment control.